Cyclophosphamide for connective tissue disease-associated interstitial lung disease (Protocol)

Research output: Contribution to journalArticleResearchpeer-review

91 Citations (Scopus)


This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy and adverse effects of cyclophosphamide in the treatment of CTD-ILD.

Original languageEnglish
Article numberCD010908
Number of pages10
JournalCochrane Database of Systematic Reviews
Issue number1
Publication statusPublished - 12 Jan 2014
Externally publishedYes

Cite this